BANK OF AMERICA CORP /DE/ - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 119 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$145,192
+10.9%
98,103
+20.6%
0.00%
Q2 2023$130,953
-96.3%
81,337
-93.3%
0.00%
Q1 2023$3,521,470
+185.2%
1,214,300
+222.6%
0.00%
Q4 2022$1,234,802
-32.5%
376,464
-22.2%
0.00%
Q3 2022$1,828,000
-32.3%
483,621
+39.6%
0.00%
Q2 2022$2,699,000
+55.8%
346,438
+85.9%
0.00%
Q1 2022$1,732,000
-11.3%
186,386
+50.5%
0.00%
Q4 2021$1,952,000
+78.4%
123,867
+102.6%
0.00%
Q3 2021$1,094,000
+79.1%
61,150
+55.7%
0.00%
Q2 2021$611,000
-63.4%
39,282
-66.3%
0.00%
Q1 2021$1,671,000
+271.3%
116,393
+407.1%
0.00%
Q4 2020$450,000
-63.9%
22,954
-76.1%
0.00%
Q3 2020$1,247,000
+191.4%
96,219
+227.9%
0.00%
Q2 2020$428,000
-72.1%
29,342
-83.7%
0.00%
Q1 2020$1,536,000
+1.0%
180,461
+95.3%
0.00%
Q4 2019$1,521,000
-16.7%
92,386
-28.5%
0.00%
Q3 2019$1,825,000
-64.0%
129,245
-48.7%
0.00%
-100.0%
Q2 2019$5,068,000
-32.3%
252,005
+33.8%
0.00%0.0%
Q1 2019$7,487,000
+125.0%
188,359
+96.7%
0.00%0.0%
Q4 2018$3,327,000
-43.2%
95,771
-32.4%
0.00%0.0%
Q3 2018$5,855,000
-45.5%
141,615
-51.5%
0.00%
-50.0%
Q2 2018$10,734,000
-32.7%
292,106
-28.6%
0.00%
-33.3%
Q1 2018$15,954,000
+775.2%
409,096
+306.0%
0.00%
Q4 2017$1,823,000
-45.0%
100,768
-49.7%
0.00%
-100.0%
Q3 2017$3,315,000
+88.5%
200,364
+59.5%
0.00%
Q2 2017$1,759,000
-34.5%
125,624
-3.8%
0.00%
-100.0%
Q1 2017$2,684,000
+60.2%
130,645
+10.7%
0.00%
Q4 2016$1,675,000
+6.6%
117,973
+60.6%
0.00%
Q3 2016$1,571,000
-8.0%
73,444
-3.3%
0.00%
Q2 2016$1,708,000
+17.3%
75,926
-0.8%
0.00%
Q1 2016$1,456,000
-27.5%
76,528
+0.7%
0.00%
Q4 2015$2,007,000
+34.7%
75,985
+60.2%
0.00%
Q3 2015$1,490,000
+1485.1%
47,432
+2555.8%
0.00%
Q2 2015$94,000
+9300.0%
1,786
+9822.2%
0.00%
Q1 2015$1,000180.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
KPCB XV Associates, LLC 1,876,650$29,182,00013.03%
Copernicus Capital Management, LLC 50,000$778,00012.27%
Antipodean Advisors LLC 1,000,000$15,550,0004.28%
BRIDGER MANAGEMENT, LLC 1,325,188$20,607,0001.92%
Redmile Group, LLC 6,449,577$100,291,0001.48%
MAVERICK CAPITAL LTD 7,704,676$119,808,0001.12%
Baupost Group 8,477,488$131,825,0001.07%
ACT CAPITAL MANAGEMENT, LLC 116,900$1,818,0000.93%
Trellus Management Company, LLC 73,056$1,136,0000.78%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$8,164,0000.75%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders